Unknown

Dataset Information

Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial.


ABSTRACT:

SUBMITTER: Zander T 

PROVIDER: S-EPMC9991905 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature